IDYA
Ideaya Biosciences Inc
NASDAQ: IDYA · HEALTHCARE · BIOTECHNOLOGY
$28.05
-3.41% today
Updated 2026-04-29
Market cap
$2.46B
P/E ratio
—
P/S ratio
11.26x
EPS (TTM)
$-1.28
Dividend yield
—
52W range
$17 – $39
Volume
1.3M
Ideaya Biosciences Inc (IDYA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-12.22M | $-27.62M | $-39.31M | $55.46M | $-55.78M | $-87.17M | $-115.22M | $-247.58M | $-71.10M |
| Capital expenditures | $1.76M | $1.71M | $1.35M | $493000.00 | $2.64M | $3.44M | $2.37M | $3.86M | $2.37M |
| Depreciation | $391000.00 | $886000.00 | $1.25M | $1.38M | $1.73M | $2.10M | $4.01M | $3.83M | — |
| Stock-based comp | $136000.00 | $950000.00 | $2.17M | $3.61M | $8.24M | $11.63M | $18.49M | $34.75M | $46.12M |
| Free cash flow | $-13.98M | $-29.33M | $-40.67M | $54.97M | $-58.42M | $-90.62M | $-117.59M | $-251.44M | $-73.47M |
| Investing cash flow | $-8.93M | $-63.18M | $2.27M | $-146.24M | $-69.67M | $-33.40M | $-158.46M | $-502.56M | — |
| Financing cash flow | $17.49M | $105.38M | $50.61M | $128.75M | $145.45M | $97.17M | $362.72M | $677.55M | — |
| Dividends paid | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $37.97M | $20.01M | $-23.41M | — | — | — |